Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
| Trial name or title | Vaccine therapy in treating patients with stage III‐IV or recurrent ovarian cancer |
| Methods | Uncontrolled phase I |
| Participants | 22 participants with advanced‐stage or recurrent ovarian cancer treated to complete remission with standard therapies |
| Interventions | pUMVC3‐hIGFBP‐2 multi‐epitope plasmid DNA vaccine |
| Outcomes | Adverse events Immune responses Survival |
| Starting date | March 2012 |
| Contact information | |
| Notes | Active April 2017; not recruiting |
